

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 9.53680905 |
| 2 | regulation of memory T cell differentiation (GO:0043380) | 6.84871321 |
| 3 | thrombin receptor signaling pathway (GO:0070493) | 6.29977561 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 5.79604335 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.55462738 |
| 6 | blood coagulation, intrinsic pathway (GO:0007597) | 5.43327309 |
| 7 | regulation of platelet aggregation (GO:0090330) | 5.10672704 |
| 8 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 5.00539921 |
| 9 | negative regulation of norepinephrine secretion (GO:0010700) | 4.95939263 |
| 10 | regulation of platelet activation (GO:0010543) | 4.84395467 |
| 11 | low-density lipoprotein particle remodeling (GO:0034374) | 4.75605864 |
| 12 | regulation of lipoprotein metabolic process (GO:0050746) | 4.69728713 |
| 13 | dopamine transport (GO:0015872) | 4.67587382 |
| 14 | negative regulation of heart rate (GO:0010459) | 4.58967973 |
| 15 | regulation of triglyceride catabolic process (GO:0010896) | 4.54790958 |
| 16 | adenosine receptor signaling pathway (GO:0001973) | 4.47639729 |
| 17 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.45610528 |
| 18 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.44130347 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.36464929 |
| 20 | L-phenylalanine catabolic process (GO:0006559) | 4.36464929 |
| 21 | negative regulation of platelet activation (GO:0010544) | 4.31821313 |
| 22 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.09100614 |
| 23 | regulation of interleukin-13 production (GO:0032656) | 4.08111458 |
| 24 | tyrosine metabolic process (GO:0006570) | 4.00914549 |
| 25 | negative regulation of protein localization to cell surface (GO:2000009) | 3.98984042 |
| 26 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.97652723 |
| 27 | platelet aggregation (GO:0070527) | 3.89980168 |
| 28 | negative regulation of appetite (GO:0032099) | 3.89665087 |
| 29 | negative regulation of response to food (GO:0032096) | 3.89665087 |
| 30 | high-density lipoprotein particle remodeling (GO:0034375) | 3.88184293 |
| 31 | lipoxygenase pathway (GO:0019372) | 3.85396116 |
| 32 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.82867630 |
| 33 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.80048008 |
| 34 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.78787194 |
| 35 | regulation of establishment of cell polarity (GO:2000114) | 3.73359679 |
| 36 | aromatic amino acid family catabolic process (GO:0009074) | 3.72454688 |
| 37 | bile acid biosynthetic process (GO:0006699) | 3.69863293 |
| 38 | amine catabolic process (GO:0009310) | 3.69352545 |
| 39 | cellular biogenic amine catabolic process (GO:0042402) | 3.69352545 |
| 40 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.69028341 |
| 41 | phospholipid homeostasis (GO:0055091) | 3.60479751 |
| 42 | reverse cholesterol transport (GO:0043691) | 3.51855825 |
| 43 | L-phenylalanine metabolic process (GO:0006558) | 3.51715716 |
| 44 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.51715716 |
| 45 | negative regulation of catecholamine secretion (GO:0033604) | 3.50953636 |
| 46 | cardiolipin metabolic process (GO:0032048) | 3.48248921 |
| 47 | neutrophil activation (GO:0042119) | 3.46968790 |
| 48 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.45435999 |
| 49 | negative regulation of multicellular organism growth (GO:0040015) | 3.44955127 |
| 50 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.40478752 |
| 51 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.40115369 |
| 52 | positive regulation of mast cell activation (GO:0033005) | 3.37463311 |
| 53 | fibrinolysis (GO:0042730) | 3.34706641 |
| 54 | ADP metabolic process (GO:0046031) | 3.27654967 |
| 55 | regulation of metalloenzyme activity (GO:0048552) | 3.27452229 |
| 56 | negative regulation of type 2 immune response (GO:0002829) | 3.26409965 |
| 57 | regulation of norepinephrine secretion (GO:0014061) | 3.26225367 |
| 58 | platelet degranulation (GO:0002576) | 3.24431075 |
| 59 | monoamine transport (GO:0015844) | 3.19488631 |
| 60 | negative regulation of blood coagulation (GO:0030195) | 3.17543045 |
| 61 | negative regulation of hemostasis (GO:1900047) | 3.17543045 |
| 62 | indole-containing compound catabolic process (GO:0042436) | 3.15556696 |
| 63 | indolalkylamine catabolic process (GO:0046218) | 3.15556696 |
| 64 | tryptophan catabolic process (GO:0006569) | 3.15556696 |
| 65 | sex differentiation (GO:0007548) | 3.15514668 |
| 66 | benzene-containing compound metabolic process (GO:0042537) | 3.15221964 |
| 67 | positive regulation of hemostasis (GO:1900048) | 3.10750512 |
| 68 | positive regulation of blood coagulation (GO:0030194) | 3.10750512 |
| 69 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.05150961 |
| 70 | regulation of integrin activation (GO:0033623) | 3.04604613 |
| 71 | polyamine biosynthetic process (GO:0006596) | 3.03569409 |
| 72 | vesicle targeting (GO:0006903) | 3.01318852 |
| 73 | regulation of hemostasis (GO:1900046) | 3.00331199 |
| 74 | regulation of blood coagulation (GO:0030193) | 3.00331199 |
| 75 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.94465468 |
| 76 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.94150084 |
| 77 | megakaryocyte development (GO:0035855) | 2.93157433 |
| 78 | catecholamine transport (GO:0051937) | 2.93111145 |
| 79 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.92992592 |
| 80 | regulation of endothelial cell differentiation (GO:0045601) | 2.92525964 |
| 81 | negative regulation of coagulation (GO:0050819) | 2.91947418 |
| 82 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.91039213 |
| 83 | regulation of female receptivity (GO:0045924) | 2.90939044 |
| 84 | granulocyte activation (GO:0036230) | 2.87902430 |
| 85 | beta-amyloid metabolic process (GO:0050435) | 2.86952849 |
| 86 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.86431624 |
| 87 | negative regulation of heart contraction (GO:0045822) | 2.84079819 |
| 88 | platelet activation (GO:0030168) | 2.83639198 |
| 89 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.83096142 |
| 90 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.82705686 |
| 91 | xenobiotic catabolic process (GO:0042178) | 2.81970158 |
| 92 | regulation of appetite (GO:0032098) | 2.79721438 |
| 93 | angiogenesis involved in wound healing (GO:0060055) | 2.79092931 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.76813075 |
| 95 | platelet formation (GO:0030220) | 2.76718838 |
| 96 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.76150708 |
| 97 | regulation of coagulation (GO:0050818) | 2.73793217 |
| 98 | purinergic receptor signaling pathway (GO:0035587) | 2.69055258 |
| 99 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.68498392 |
| 100 | cholesterol catabolic process (GO:0006707) | 2.68495684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 4.22969346 |
| 2 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.76952378 |
| 3 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.47521108 |
| 4 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.15315909 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.73346691 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.68043865 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 2.56777240 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.55824885 |
| 9 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.37789706 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.34296164 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.32964246 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.24295047 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.21407801 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.20685368 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.12897570 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.10178999 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.03758992 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.01402279 |
| 19 | GATA1_19941826_ChIP-Seq_K562_Human | 1.96766587 |
| 20 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.96598544 |
| 21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.96485121 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.88471931 |
| 23 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.86528490 |
| 24 | GATA2_19941826_ChIP-Seq_K562_Human | 1.86307498 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.83336904 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73057347 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.70941862 |
| 28 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64663216 |
| 29 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.60590902 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.60551447 |
| 31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.60311971 |
| 32 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.56095271 |
| 33 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.54142100 |
| 34 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.54142100 |
| 35 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52841137 |
| 36 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.47686720 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.44866704 |
| 38 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43603566 |
| 39 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.42688823 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40451883 |
| 41 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.40064147 |
| 42 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.31988164 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31454986 |
| 44 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30636451 |
| 45 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.29211128 |
| 46 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27403111 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26887171 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25313813 |
| 49 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25270026 |
| 50 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.23720051 |
| 51 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.22614690 |
| 52 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21662076 |
| 53 | AR_20517297_ChIP-Seq_VCAP_Human | 1.21121978 |
| 54 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.19229656 |
| 55 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.19229656 |
| 56 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.18990109 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17153504 |
| 58 | EWS_26573619_Chip-Seq_HEK293_Human | 1.16429398 |
| 59 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.15267307 |
| 60 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.14858087 |
| 61 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.12949131 |
| 62 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10856709 |
| 63 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10523546 |
| 64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.10031508 |
| 65 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09483130 |
| 66 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09039913 |
| 67 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08111858 |
| 68 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.07990705 |
| 69 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.07990705 |
| 70 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07966781 |
| 71 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07677418 |
| 72 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.07534939 |
| 73 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.07425798 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07075186 |
| 75 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.06538716 |
| 76 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.06531303 |
| 77 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05966890 |
| 78 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.05333752 |
| 79 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00729059 |
| 80 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99199658 |
| 81 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.98531687 |
| 82 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98410736 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98127435 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.98020140 |
| 85 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97922083 |
| 86 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.97608503 |
| 87 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95775720 |
| 88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95625015 |
| 89 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.95387640 |
| 90 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.95383106 |
| 91 | STAT3_23295773_ChIP-Seq_U87_Human | 0.94324565 |
| 92 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.94178395 |
| 93 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93759549 |
| 94 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92154902 |
| 95 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.91312024 |
| 96 | FUS_26573619_Chip-Seq_HEK293_Human | 0.90735178 |
| 97 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.90727166 |
| 98 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90063743 |
| 99 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89884023 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89591534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 8.73021345 |
| 2 | MP0008004_abnormal_stomach_pH | 3.84484295 |
| 3 | MP0003724_increased_susceptibility_to | 3.30005626 |
| 4 | MP0003252_abnormal_bile_duct | 3.09873093 |
| 5 | MP0003011_delayed_dark_adaptation | 2.77183215 |
| 6 | MP0002736_abnormal_nociception_after | 2.72619646 |
| 7 | MP0000465_gastrointestinal_hemorrhage | 2.38561077 |
| 8 | MP0004130_abnormal_muscle_cell | 2.35378860 |
| 9 | MP0009697_abnormal_copulation | 2.27542278 |
| 10 | MP0000230_abnormal_systemic_arterial | 2.14715455 |
| 11 | MP0004510_myositis | 2.09867056 |
| 12 | MP0008872_abnormal_physiological_respon | 1.94521759 |
| 13 | MP0005410_abnormal_fertilization | 1.91631589 |
| 14 | MP0001835_abnormal_antigen_presentation | 1.90732755 |
| 15 | MP0001879_abnormal_lymphatic_vessel | 1.88057653 |
| 16 | MP0001968_abnormal_touch/_nociception | 1.83439194 |
| 17 | MP0010329_abnormal_lipoprotein_level | 1.82325450 |
| 18 | MP0005646_abnormal_pituitary_gland | 1.80557052 |
| 19 | MP0003638_abnormal_response/metabolism_ | 1.79829848 |
| 20 | MP0006036_abnormal_mitochondrial_physio | 1.78798938 |
| 21 | MP0001545_abnormal_hematopoietic_system | 1.73431241 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 1.73431241 |
| 23 | MP0000343_altered_response_to | 1.73368285 |
| 24 | MP0005085_abnormal_gallbladder_physiolo | 1.65950451 |
| 25 | MP0004147_increased_porphyrin_level | 1.64539387 |
| 26 | MP0010386_abnormal_urinary_bladder | 1.60398278 |
| 27 | MP0005083_abnormal_biliary_tract | 1.58058224 |
| 28 | MP0009763_increased_sensitivity_to | 1.56769738 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.51085423 |
| 30 | MP0001986_abnormal_taste_sensitivity | 1.50259328 |
| 31 | MP0005671_abnormal_response_to | 1.49202568 |
| 32 | MP0005084_abnormal_gallbladder_morpholo | 1.41560535 |
| 33 | MP0003718_maternal_effect | 1.37837045 |
| 34 | MP0008875_abnormal_xenobiotic_pharmacok | 1.36687199 |
| 35 | MP0000569_abnormal_digit_pigmentation | 1.33568388 |
| 36 | MP0009765_abnormal_xenobiotic_induced | 1.33280791 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.31179741 |
| 38 | MP0002148_abnormal_hypersensitivity_rea | 1.30746821 |
| 39 | MP0002733_abnormal_thermal_nociception | 1.29980108 |
| 40 | MP0005365_abnormal_bile_salt | 1.28003325 |
| 41 | MP0004215_abnormal_myocardial_fiber | 1.23943659 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.23619632 |
| 43 | MP0001666_abnormal_nutrient_absorption | 1.23506290 |
| 44 | MP0002132_abnormal_respiratory_system | 1.19971540 |
| 45 | MP0000249_abnormal_blood_vessel | 1.19277044 |
| 46 | MP0003828_pulmonary_edema | 1.18260604 |
| 47 | MP0005000_abnormal_immune_tolerance | 1.17807002 |
| 48 | MP0003186_abnormal_redox_activity | 1.15543178 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 1.14856579 |
| 50 | MP0003303_peritoneal_inflammation | 1.13322665 |
| 51 | MP0009642_abnormal_blood_homeostasis | 1.11141242 |
| 52 | MP0005647_abnormal_sex_gland | 1.07328806 |
| 53 | MP0001851_eye_inflammation | 1.06194359 |
| 54 | MP0002398_abnormal_bone_marrow | 1.05854018 |
| 55 | MP0005636_abnormal_mineral_homeostasis | 1.05651684 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.05183785 |
| 57 | MP0002139_abnormal_hepatobiliary_system | 1.04998205 |
| 58 | MP0008775_abnormal_heart_ventricle | 1.02828701 |
| 59 | MP0008961_abnormal_basal_metabolism | 1.02398078 |
| 60 | MP0004019_abnormal_vitamin_homeostasis | 0.99258416 |
| 61 | MP0000685_abnormal_immune_system | 0.98603370 |
| 62 | MP0001756_abnormal_urination | 0.97940665 |
| 63 | MP0001800_abnormal_humoral_immune | 0.97347922 |
| 64 | MP0001765_abnormal_ion_homeostasis | 0.97147086 |
| 65 | MP0003879_abnormal_hair_cell | 0.95836615 |
| 66 | MP0001663_abnormal_digestive_system | 0.95804487 |
| 67 | MP0004084_abnormal_cardiac_muscle | 0.94771086 |
| 68 | MP0005448_abnormal_energy_balance | 0.93324511 |
| 69 | MP0005310_abnormal_salivary_gland | 0.92697541 |
| 70 | MP0004947_skin_inflammation | 0.90898098 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 0.90829622 |
| 72 | MP0006138_congestive_heart_failure | 0.90643748 |
| 73 | MP0000358_abnormal_cell_content/ | 0.86567145 |
| 74 | MP0006276_abnormal_autonomic_nervous | 0.86551860 |
| 75 | MP0000689_abnormal_spleen_morphology | 0.86240705 |
| 76 | MP0002723_abnormal_immune_serum | 0.86223319 |
| 77 | MP0004036_abnormal_muscle_relaxation | 0.83360766 |
| 78 | MP0001845_abnormal_inflammatory_respons | 0.83097992 |
| 79 | MP0003866_abnormal_defecation | 0.81585008 |
| 80 | MP0002452_abnormal_antigen_presenting | 0.80595673 |
| 81 | MP0009764_decreased_sensitivity_to | 0.80536162 |
| 82 | MP0004808_abnormal_hematopoietic_stem | 0.79631086 |
| 83 | MP0005187_abnormal_penis_morphology | 0.78096559 |
| 84 | MP0000383_abnormal_hair_follicle | 0.75921340 |
| 85 | MP0002429_abnormal_blood_cell | 0.74551567 |
| 86 | MP0001970_abnormal_pain_threshold | 0.72640193 |
| 87 | MP0001664_abnormal_digestion | 0.72392249 |
| 88 | MP0002722_abnormal_immune_system | 0.72170294 |
| 89 | MP0005334_abnormal_fat_pad | 0.71426720 |
| 90 | MP0001764_abnormal_homeostasis | 0.71134671 |
| 91 | MP0005332_abnormal_amino_acid | 0.70394167 |
| 92 | MP0002420_abnormal_adaptive_immunity | 0.70316626 |
| 93 | MP0001819_abnormal_immune_cell | 0.69882705 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 0.69403682 |
| 95 | MP0001533_abnormal_skeleton_physiology | 0.68615158 |
| 96 | MP0009643_abnormal_urine_homeostasis | 0.68254390 |
| 97 | MP0003868_abnormal_feces_composition | 0.67072239 |
| 98 | MP0009840_abnormal_foam_cell | 0.66957216 |
| 99 | MP0000609_abnormal_liver_physiology | 0.66874158 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.65853379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 8.72317162 |
| 2 | Menorrhagia (HP:0000132) | 7.94946761 |
| 3 | Increased mean platelet volume (HP:0011877) | 7.69062991 |
| 4 | Abnormal platelet volume (HP:0011876) | 7.25595129 |
| 5 | Petechiae (HP:0000967) | 6.84005752 |
| 6 | Purpura (HP:0000979) | 6.36218259 |
| 7 | Epistaxis (HP:0000421) | 6.34518063 |
| 8 | Gingival bleeding (HP:0000225) | 6.24212327 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 6.22284806 |
| 10 | Impaired platelet aggregation (HP:0003540) | 4.76931150 |
| 11 | Abnormal platelet function (HP:0011869) | 4.76931150 |
| 12 | Generalized aminoaciduria (HP:0002909) | 4.66148184 |
| 13 | Genetic anticipation (HP:0003743) | 4.13646504 |
| 14 | Dyschromatopsia (HP:0007641) | 3.91435398 |
| 15 | Dysmetric saccades (HP:0000641) | 3.86258092 |
| 16 | Poikilocytosis (HP:0004447) | 3.83988728 |
| 17 | Acanthocytosis (HP:0001927) | 3.83732119 |
| 18 | Renal cortical cysts (HP:0000803) | 3.65257842 |
| 19 | Spontaneous hematomas (HP:0007420) | 3.54136213 |
| 20 | Decreased central vision (HP:0007663) | 3.42874921 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 3.36832902 |
| 22 | Abnormal pupillary function (HP:0007686) | 3.34466362 |
| 23 | Abnormality of the prostate (HP:0008775) | 3.26046177 |
| 24 | Prostate neoplasm (HP:0100787) | 3.18366702 |
| 25 | Tinnitus (HP:0000360) | 3.17552057 |
| 26 | Spontaneous abortion (HP:0005268) | 3.10946145 |
| 27 | Joint hemorrhage (HP:0005261) | 3.09623910 |
| 28 | Proximal tubulopathy (HP:0000114) | 2.95012937 |
| 29 | Abnormality of the hepatic vasculature (HP:0006707) | 2.85581383 |
| 30 | Pendular nystagmus (HP:0012043) | 2.85531872 |
| 31 | Progressive cerebellar ataxia (HP:0002073) | 2.84687356 |
| 32 | 3-Methylglutaconic aciduria (HP:0003535) | 2.82930275 |
| 33 | Paralysis (HP:0003470) | 2.78806472 |
| 34 | Action tremor (HP:0002345) | 2.76728371 |
| 35 | Bruising susceptibility (HP:0000978) | 2.75119491 |
| 36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.64507984 |
| 37 | Conjunctival telangiectasia (HP:0000524) | 2.61860176 |
| 38 | Hyperthyroidism (HP:0000836) | 2.58688961 |
| 39 | Biliary tract neoplasm (HP:0100574) | 2.55409118 |
| 40 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.52743397 |
| 41 | Postural tremor (HP:0002174) | 2.43292965 |
| 42 | Nausea (HP:0002018) | 2.42462456 |
| 43 | Abnormal auditory evoked potentials (HP:0006958) | 2.37241995 |
| 44 | Increased density of long bones (HP:0006392) | 2.34910484 |
| 45 | Congenital, generalized hypertrichosis (HP:0004540) | 2.27790323 |
| 46 | Hypochromic microcytic anemia (HP:0004840) | 2.22999574 |
| 47 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.22873462 |
| 48 | Abnormality of the renal cortex (HP:0011035) | 2.22445905 |
| 49 | Absence seizures (HP:0002121) | 2.21217824 |
| 50 | Abnormality of iron homeostasis (HP:0011031) | 2.20951531 |
| 51 | Abnormal ciliary motility (HP:0012262) | 2.20145466 |
| 52 | Joint swelling (HP:0001386) | 2.17468279 |
| 53 | Abnormality of methionine metabolism (HP:0010901) | 2.17332037 |
| 54 | Xanthomatosis (HP:0000991) | 2.16440201 |
| 55 | Gaze-evoked nystagmus (HP:0000640) | 2.15814308 |
| 56 | Abnormality of alanine metabolism (HP:0010916) | 2.15579391 |
| 57 | Hyperalaninemia (HP:0003348) | 2.15579391 |
| 58 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.15579391 |
| 59 | Severe visual impairment (HP:0001141) | 2.13757585 |
| 60 | Fair hair (HP:0002286) | 2.11981645 |
| 61 | Thyroid-stimulating hormone excess (HP:0002925) | 1.99868058 |
| 62 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.96835195 |
| 63 | Impaired vibratory sensation (HP:0002495) | 1.92244792 |
| 64 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.90994450 |
| 65 | Abnormality of lateral ventricle (HP:0030047) | 1.90470355 |
| 66 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88671113 |
| 67 | Chronic sinusitis (HP:0011109) | 1.86868135 |
| 68 | Arterial thrombosis (HP:0004420) | 1.86853688 |
| 69 | Encephalitis (HP:0002383) | 1.85092607 |
| 70 | Hypophosphatemic rickets (HP:0004912) | 1.84608098 |
| 71 | Clumsiness (HP:0002312) | 1.84169624 |
| 72 | Abnormal spermatogenesis (HP:0008669) | 1.79594919 |
| 73 | Abnormal number of erythroid precursors (HP:0012131) | 1.79169581 |
| 74 | Male infertility (HP:0003251) | 1.78449234 |
| 75 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.77459458 |
| 76 | Absent/shortened dynein arms (HP:0200106) | 1.77459458 |
| 77 | Autoimmune hemolytic anemia (HP:0001890) | 1.76524138 |
| 78 | Hypobetalipoproteinemia (HP:0003563) | 1.76389692 |
| 79 | Hepatosplenomegaly (HP:0001433) | 1.74831365 |
| 80 | Prolonged partial thromboplastin time (HP:0003645) | 1.74829352 |
| 81 | Arthropathy (HP:0003040) | 1.73022656 |
| 82 | Renal Fanconi syndrome (HP:0001994) | 1.69305696 |
| 83 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.69300981 |
| 84 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.69300981 |
| 85 | Postural instability (HP:0002172) | 1.68990402 |
| 86 | Abnormality of male internal genitalia (HP:0000022) | 1.68778053 |
| 87 | Increased serum ferritin (HP:0003281) | 1.66390739 |
| 88 | Increased IgM level (HP:0003496) | 1.63923443 |
| 89 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.62805437 |
| 90 | Slow saccadic eye movements (HP:0000514) | 1.62530906 |
| 91 | Portal hypertension (HP:0001409) | 1.59358800 |
| 92 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.59207352 |
| 93 | Obstructive lung disease (HP:0006536) | 1.58719260 |
| 94 | Chronic obstructive pulmonary disease (HP:0006510) | 1.58719260 |
| 95 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.57980586 |
| 96 | Abnormal biliary tract morphology (HP:0012440) | 1.57773709 |
| 97 | Tongue fasciculations (HP:0001308) | 1.54874986 |
| 98 | Abnormality of urine glucose concentration (HP:0011016) | 1.54077340 |
| 99 | Glycosuria (HP:0003076) | 1.54077340 |
| 100 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.52577654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK19 | 5.31854236 |
| 2 | MST4 | 4.91591329 |
| 3 | INSRR | 3.73929155 |
| 4 | RIPK4 | 3.56066108 |
| 5 | OXSR1 | 3.44998999 |
| 6 | EIF2AK1 | 3.07848091 |
| 7 | BMX | 3.02423619 |
| 8 | MYLK | 2.78946388 |
| 9 | TEC | 2.75936985 |
| 10 | PIK3CG | 2.53312712 |
| 11 | BTK | 2.47837147 |
| 12 | BMPR2 | 2.34958450 |
| 13 | TNK2 | 2.23575653 |
| 14 | TAOK3 | 2.12776317 |
| 15 | FRK | 2.04920838 |
| 16 | BMPR1B | 1.90307313 |
| 17 | PTK2B | 1.86961303 |
| 18 | ACVR1B | 1.82390061 |
| 19 | CSF1R | 1.80916968 |
| 20 | GRK5 | 1.67646641 |
| 21 | MAP4K2 | 1.57718701 |
| 22 | ILK | 1.51735475 |
| 23 | TXK | 1.50403312 |
| 24 | SYK | 1.46933082 |
| 25 | STK3 | 1.46856803 |
| 26 | ADRBK2 | 1.42959894 |
| 27 | GRK6 | 1.35441381 |
| 28 | BRSK2 | 1.26641028 |
| 29 | MUSK | 1.25718814 |
| 30 | MAPKAPK3 | 1.20665907 |
| 31 | GRK1 | 1.19850062 |
| 32 | ZAP70 | 1.16856124 |
| 33 | CDK8 | 1.14287396 |
| 34 | FGR | 1.12302279 |
| 35 | RPS6KB2 | 1.00880730 |
| 36 | VRK1 | 0.94328661 |
| 37 | ADRBK1 | 0.91722056 |
| 38 | FER | 0.86588983 |
| 39 | HCK | 0.85642073 |
| 40 | STK16 | 0.85324084 |
| 41 | LYN | 0.83186462 |
| 42 | DAPK3 | 0.82974368 |
| 43 | TLK1 | 0.80587926 |
| 44 | ITK | 0.78842972 |
| 45 | ZAK | 0.76347663 |
| 46 | IKBKB | 0.76342414 |
| 47 | RET | 0.75459248 |
| 48 | FES | 0.74444699 |
| 49 | PAK1 | 0.74064254 |
| 50 | DAPK2 | 0.71079820 |
| 51 | PLK2 | 0.65979861 |
| 52 | MATK | 0.65870672 |
| 53 | NUAK1 | 0.65613187 |
| 54 | STK24 | 0.64032423 |
| 55 | NEK9 | 0.63721792 |
| 56 | JAK2 | 0.63513310 |
| 57 | PDK1 | 0.62745013 |
| 58 | TGFBR1 | 0.60377101 |
| 59 | STK39 | 0.59780299 |
| 60 | BLK | 0.56677405 |
| 61 | PDGFRB | 0.55568154 |
| 62 | MAP3K12 | 0.55492392 |
| 63 | LMTK2 | 0.55343189 |
| 64 | CAMKK2 | 0.54743709 |
| 65 | ERBB2 | 0.53747110 |
| 66 | EPHA3 | 0.51730620 |
| 67 | WNK4 | 0.51522934 |
| 68 | TRPM7 | 0.50266330 |
| 69 | PDPK1 | 0.49199828 |
| 70 | PAK2 | 0.48530293 |
| 71 | MKNK1 | 0.48456188 |
| 72 | CDK9 | 0.48287660 |
| 73 | PRKACG | 0.45644442 |
| 74 | MAP3K5 | 0.41976482 |
| 75 | MKNK2 | 0.39761898 |
| 76 | PIM2 | 0.39210337 |
| 77 | IGF1R | 0.38103447 |
| 78 | LCK | 0.37823571 |
| 79 | PNCK | 0.37684141 |
| 80 | MAP2K1 | 0.36978353 |
| 81 | PRKCD | 0.36503698 |
| 82 | PAK3 | 0.36204052 |
| 83 | PRKG1 | 0.33760702 |
| 84 | IRAK1 | 0.33230231 |
| 85 | AURKA | 0.32861858 |
| 86 | PIK3CA | 0.31413144 |
| 87 | MAP2K3 | 0.27643732 |
| 88 | MARK3 | 0.27305996 |
| 89 | MAPK11 | 0.26924216 |
| 90 | PRKD1 | 0.25976757 |
| 91 | ERBB3 | 0.22797270 |
| 92 | HIPK2 | 0.21820926 |
| 93 | JAK1 | 0.21438089 |
| 94 | STK4 | 0.19894881 |
| 95 | PRKCB | 0.19630821 |
| 96 | PRKAA2 | 0.18822221 |
| 97 | PRKCA | 0.17524336 |
| 98 | PKN1 | 0.17111350 |
| 99 | PRKACA | 0.16947925 |
| 100 | PLK3 | 0.16072824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 5.20057223 |
| 2 | Platelet activation_Homo sapiens_hsa04611 | 4.18898041 |
| 3 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.79354715 |
| 4 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.89189428 |
| 5 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.74779977 |
| 6 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.65196357 |
| 7 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.54958132 |
| 8 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.51961336 |
| 9 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.48729727 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.00852029 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.98343172 |
| 12 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96067604 |
| 13 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.94452749 |
| 14 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.88067091 |
| 15 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87947624 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.78809704 |
| 17 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.72006173 |
| 18 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.58983172 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.55942400 |
| 20 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.48700349 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42957290 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.41457624 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.38646428 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.32037165 |
| 25 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.31655039 |
| 26 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.30341759 |
| 27 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.28477303 |
| 28 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.25095868 |
| 29 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23548848 |
| 30 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.23097325 |
| 31 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.19298065 |
| 32 | Ribosome_Homo sapiens_hsa03010 | 1.18475117 |
| 33 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15423307 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.08854563 |
| 35 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07920110 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.07202662 |
| 37 | Olfactory transduction_Homo sapiens_hsa04740 | 1.05697434 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03040080 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99283423 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.89953778 |
| 41 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.89421503 |
| 42 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88308752 |
| 43 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.88155693 |
| 44 | Alcoholism_Homo sapiens_hsa05034 | 0.87983216 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.87978695 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 0.86801195 |
| 47 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86430946 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.84812609 |
| 49 | Phototransduction_Homo sapiens_hsa04744 | 0.84682706 |
| 50 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83855792 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81396667 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80833486 |
| 53 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80410837 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78399841 |
| 55 | Parkinsons disease_Homo sapiens_hsa05012 | 0.76829902 |
| 56 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.74300584 |
| 57 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.73391114 |
| 58 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.72780920 |
| 59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71657979 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 0.69075339 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69028993 |
| 62 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66208351 |
| 63 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62435872 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60880190 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60756060 |
| 66 | Purine metabolism_Homo sapiens_hsa00230 | 0.55888938 |
| 67 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51003052 |
| 68 | Basal transcription factors_Homo sapiens_hsa03022 | 0.48007481 |
| 69 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.47511944 |
| 70 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46305406 |
| 71 | Long-term depression_Homo sapiens_hsa04730 | 0.45803953 |
| 72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44394666 |
| 73 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44375503 |
| 74 | Morphine addiction_Homo sapiens_hsa05032 | 0.43601810 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.42714397 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42603997 |
| 77 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42253677 |
| 78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.41000939 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40982856 |
| 80 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.40561272 |
| 81 | Taste transduction_Homo sapiens_hsa04742 | 0.40544550 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.40393375 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38636659 |
| 84 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.36377070 |
| 85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35048789 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34744539 |
| 87 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.33522527 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32341169 |
| 89 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.31860929 |
| 90 | Melanoma_Homo sapiens_hsa05218 | 0.30737426 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30346796 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29793414 |
| 93 | Sulfur relay system_Homo sapiens_hsa04122 | 0.28097354 |
| 94 | Mismatch repair_Homo sapiens_hsa03430 | 0.28035773 |
| 95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.27760913 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27373911 |
| 97 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25629531 |
| 98 | Renin secretion_Homo sapiens_hsa04924 | 0.23838853 |
| 99 | Homologous recombination_Homo sapiens_hsa03440 | 0.23724875 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23632924 |

